8):555-560 ▪ https://doi.org/10.20344/amp.7930 RESUMO Introdução: O valor do hematócrito tem sido estudado como preditor de resultados. O objetivo deste estudo foi avaliar a relação entre um hematócrito baixo na admissão a uma unidade de cuidados intensivos cirúrgica e os sistemas de gravidade bem como o seu impacto nos resultados tendo em conta as complicações e a mortalidade. Material e Métodos: Estudo retrospetivo incluindo 4398 doentes internados numa Unidade de Cuidados Intensivos Cirúrgica entre janeiro de 2006 e julho de 2013. Foram calculados os scores de gravidade acute physiology and chronic health evaluation II e o simplified acute physiology score II, e todas as variáveis inseridas como parâmetros foram avaliadas separadamente. Os doentes com um hematócrito à admissão na Unidade de Cuidados Intensivos Cirúrgica inferior a 30 foram classificados como doentes com hematócrito baixo. A relação entre o hematócrito na admissão e as complicações e o resultado foram avaliados com uma análise univariada e uma regressão linear. Resultados: Os doentes com classificados como doentes com hematócrito baixo foram 1126 (25,6%). Os doentes classificados como doentes com hematócrito baixo tiveram mais frequentemente eventos cardíacos major (4% vs 1,9%, p < 0,001), lesão renal aguda (11,5% vs 4,7%, p < 0,001) e maiores taxas de mortalidade quer na Unidade de Cuidados Intensivos Cirúrgica (3% vs 0,8%, p < 0,001) quer no internamento hospitalar (12% vs 5,9%, p < 0,001). Discussão: Um valor de hematócrito < 30% na admissão na Unidade de Cuidados Intensivos foi frequente e parece ser um preditor de piores resultados em doentes cirúrgicos críticos. Conclusão: Os doentes com hematócrito baixo tiveram mais tempo de internamento na Unidade de Cuidados Intensivos Cirúrgica e no hospital, tiveram mais complicações pós-operatórias e taxas de mortalidade na Unidade de Cuidados Intensivos Cirúrgica e no hospital mais elevadas.
INTRODUCTION
Several factors may impair organic homeostasis under surgical stress and influence the outcomes of high-risk patients. 1 Anaemia is a common multifactorial condition in intensive care units (ICU). 2, 3 The deleterious effects of anaemia include an increased risk of cardiac-related morbidity and mortality, 4 in part due to a decreased oxygencarrying capacity. Since critical illness increases metabolic demands, the consequences of anaemia could be more significant in this population. 4, 5 Even mild anaemia (29% < HTC ≤ 39% in men and 29% < HTC ≤ 36% in women) has been reported as an independent factor that increases 30day mortality rates. 6, 7 On the other hand, the transfusion of only one unit of red blood cells significantly increases 30day mortality rates. 8 Haematocrit (HTC) has been studied as a transfusion trigger and outcome predictor. 9 It is known that values < 30% can be tolerated by many patients; however, it is unclear whether this is true in critically ill patients.
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Lopes AM, et al. Postoperative haematocrit and outcome in critically ill surgical patients, Acta Med Port 2017 Jul-Aug;30 (7) (8) : [555] [556] [557] [558] [559] [560] Despite the demonstrated correlation between lower HTC levels and poorer outcomes, the specific impact of anaemia on ICU patient morbidity and mortality rates has yet to be defined. 10, 11 As such, the optimal anaemia management standards remain controversial. In surgical patients, HTC levels during 24 hour SICU admission depend on preoperative status and perioperative management. Complications following major surgery are a leading cause of morbidity and mortality, 7 while the general surgical population has become older and sicker. 12 In this set of sicker patients, the initial assessment is essential for risk stratification and management adjustment. Moreover, it is crucial to establish criteria to classify a patient's risk when the use of a surgical procedure is proposed. 13 Many risk models have been designed to characterize disease severity and predict outcome and organ dysfunction degree in the postoperative setting. The acute physiology and chronic health evaluation (APACHE) II and simplified acute physiology score (SAPS) II are two of the most commonly used tools. The APACHE II score varies from 0 to 71 points and is based upon age, previous health status, and 12 routine physiologic measurements. 14 It is closely correlated with the risk of hospital death and enables the stratification of acutely ill patients. SAPS II values are calculated using 12 physiological variables and consider pre-admission health status and age. 15 APACHE II and SAPS II scores perform similarly in predicting the outcomes of patients in the SICU. 16 Major cardiac events (MCE) are relatively uncommon but associated with longer hospital stays, higher treatment costs, and higher mortality and morbidity rates. 17 The frequency of these episodes varies considerably depending on the characteristics of the studied population, but an incidence of 2% -4% might be an accurate estimate. [18] [19] [20] These events might be difficult to predict since they frequently cause no early symptoms 21 or electrocardiography changes. Therefore, an accurate preoperative assessment is essential for guiding an individualized patient approach, establishing prophylactic treatment, optimizing perioperative management, and enabling the early detection of possible cardiac complications.
A better understanding of outcome predictors in critical surgical patients will allow an individualized perioperative approach, the establishment of prophylactic measures, and the early detection of complications. Few studies have focused on postoperative HTC, and to our knowledge, only one study focused on a critical surgical population, although it was restricted to vascular patients. 22 Therefore, this study aimed to evaluate the correlation between LHTC at surgical intensive care unit (SICU) admission, high disease scoring system scores, and the impact of HTC on early outcomes according to patient complications and hospital mortality rates.
MATERIAL AND METHODS
Upon receiving approval from the institutional research ethics committee, we conducted this retrospective cohort study at the post-anaesthesia care unit of a tertiary care centre. This unit has a five-bed SICU where patients are closely monitored and treated. SICU admissions were determined according to surgical risk, previous heath status, and the occurrence of adverse events. All patients underwent non-cardiac surgery between 1 January 2006 and 19 July 2013, and those who were admitted to the SICU were eligible for inclusion. Patients were excluded if they were < 18 years of age, non-surgical patients, re-admitted for the same medical reason during the study period, or in the SICU for < 12 hours.
Patients with an HTC value < 30% were considered to have low HTC (LHTC). At SICU admission, patient demographic and perioperative data such as age, sex, and surgery type (elective or urgent) were collected. An individual cardiac risk profile, namely the Revised Cardiac Risk Index (RCRI) developed by Lee et al, was scored. The RCRI consists of the following variables: high-risk surgery, history of congestive heart failure, history of ischemic heart disease, history of cerebrovascular disease, insulin therapy for diabetes, and preoperative serum creatinine > 2.0 mg/ dL. 18 APACHE II and SAPS II values were both calculated as originally described [4, 5] . The variables included the following: hemodynamic factors; complete blood counts; blood biochemistry values including HTC, leucocyte count, serum sodium, bicarbonate, bilirubin, urea, creatinine, and potassium levels; systolic and mean arterial blood pressure; body temperature; heart and respiratory rate; arterial pH, PaO 2 , and PaCO 2 ; and Glasgow Coma Scale score. The failure of at least one organ, defined according to the APACHE II score, was recorded as organ insufficiency. The need for mechanical ventilation and the fraction of inspired oxygen at admission were also documented.
Postoperative complications, specifically MCE, acute renal failure (ARF), or death, were recorded. We defined MCE as the occurrence of acute myocardial infarction (according to the European Society of Cardiology/American College of Cardiology criteria), 23 pulmonary oedema, ventricular fibrillation, primary cardiac arrest, or complete heart block. Creatinine > 2 mg/dL, associated with a urinary debit < 500 mL/d, was identified as ARF. Length of stay (LOS) in the SICU was also recorded.
A descriptive analysis was performed to summarize the collected data. Data are presented as median and percentile interval (P25 -P75) for continuous variables after confirmation on the Kolmogorov-Smirnov test that they did not follow a normal distribution.
Variables were compared on univariate analysis. The chi-square or Fischer's exact test was used to compare categorical variables, while the Mann-Whitney U test was used to compare continuous variables. Linear regression was used to determine the impact of HTC on high disease scoring system score and SICU LOS. Additionally, logistic regression was performed to assess the covariate effects of HTC on mortality, LOS, and complications with the Lopes AM, et al. Postoperative haematocrit and outcome in critically ill surgical patients, Acta Med Port 2017 Jul-Aug;30 (7) (8) :555-560 calculation of odds ratio (OR) and its 95% confidence interval (CI). Because of multiple comparisons effects, the variables were considered significant at values of p ≤ 0.001.
RESULTS
During the study period, 4398 patients met the inclusion criteria. The following 163 patients were excluded: 53 had a LOS < 12 hour, 42 were re-admitted, 38 were <18 years of age, and 30 were non-surgical patients. Demographics and perioperative data are presented in Table 1 p < 0.001). A higher proportion of patients with LHTC had MCE (4% vs 1.9%, p < 0.001) or ARF (11.5% vs 4.7%, p < 0.001), and they were more likely to stay longer in the SICU (32 vs 20 hours, p < 0.001). Likewise, LHTC patients had higher SICU mortality rates in the SICU (3% vs 0.8%, p < 0.001) and in hospital (12% vs 5.9%, p < 0.001). During 24-hour SICU admission, patients with LHTC had a lower mean body temperature (p < 0.001), arterial systolic pressure (p < 0.001), and mean arterial pressure (p < 0.001) as well as a higher heart rate (p < 0.001), serum creatinine (p < 0.001), and FiO 2 (p < 0.001) than patients with HTC > 30%. Table 2 presents data related to disease scoring system score and individual cardiac risk profile (namely RCRI) accordingly to HTC level. A higher proportion of patients with LHTC had a history of renal disease (10.8% vs 4.9%, p < 0.001) and RCRI > 2 (10.8% vs. 6.7%, p < 0.001); however, a lower proportion had a history of cerebrovascular disease (9.9% vs 13.7%, p < 0.001). Regarding disease scores, LHTC patients had higher mean APACHE II (11 vs 8, p < 0.001) and SAPS II scores (24.4 vs 17.8, p < 0.001).
On linear regression (Table 3) , for each unit increase in HTC value, the APACHE II score decreases 0.25 (95% CI, -0.27 to -0.22; p < 0.001) and SAPS II score decreases 0.39 (95% CI, -0.52 to -0.26; p < 0.001). In addition, the SICU LOS decreases by 1.38 hours (95% CI; -1.60 to -1.16; p < 0.001) for each unit increase in HTC value.
Regarding the occurrence of postoperative complications (Table 4) , an increase in HTC was considered a protective factor for MCE (p < 0.001; OR, 0.93; 95% CI, 0.83 -0.91) and for mortality in the SICU (p < 0.001; OR, 0.87; 95% CI, 0.83 -0.91) or hospital (p < 0.001; OR, 0.9; 95% CI, 0.90 -0.94).
DISCUSSION
To our knowledge, this is the first study of postoperative HTC and outcomes in selected non-cardiac critical surgical patients.
Surgical blood loss is an important determining factor of patients' postoperative HTC levels, but even without significant blood loss, they may have significant reductions in HTC that are not entirely explained by intraoperative blood loss or dilution. 24, 25 In critically ill patients, the body's erythropoietic response to anaemia is blunted as a consequence of diminished iron availability and the direct inhibitory effects of inflammatory cytokines. 26 Several studies have assessed the correlation between lower preoperative HTC level and worse outcome in surgical patients. 27, 28 However, due to the high frailty of critically ill patients and the huge variability of the stress imposed by surgery or blood loss, we suppose that postoperative HTC in a selected population is more reliable than preoperative HTC for predicting patient outcomes.
In our study, patients with LHTC were more likely to have a longer SICU LOS or die in the SICU, which are similar to the results reported by Mudumbai et al. 9 In that study, the authors stated that patients with an HTC < 30% during the 24-hour ICU admission were more likely to have a longer hospital LOS and to die within 1 year postdischarge. Moreover, they described the highest mortality rate in patients with an HTC level < 25% and reported that the benefits of red blood cell transfusions outweigh the risks in this group only. In our study on critical care patients, all patients had surgical stress in common as an ensuing reason to an impaired response to anaemia. Wu et al 29 also reported higher postoperative mortality rates within 30 days in patients with preoperative lower HTC. In our study, LHTC patients more frequently had a preoperative serum creatinine level > 2.0 mg/dL and were more likely to develop ARF in the SICU. This correlation between anaemia and renal function is explained by the fact that both anaemia and renal disease are risk factors for ARF. 30 Moreover, LHTC patients were more likely to have lower systolic and mean arterial pressures, which are also risk factors for ARF.
There are differences in compensatory responses to anaemia between healthy and severely ill patients. 22 According to our results, HTC level is closely correlated with disease scores (namely APACHE II and SAPS II), which may indicate more severe underlying disease in patients with LHTC. This could explain why patients with LHTC appear to be more fragile and, therefore, are more likely to experience adverse events like MCE or death.
HTC is a component of diseases scoring systems, although its role as a risk factor for morbidity and mortality is incompletely understood. The knowledge of its importance will enable better management of current therapies available for HTC correction and help establish a trigger for transfusion, which still lacks consensus in the literature. 5, 9 MCE were more common in LHTC patients, which was also noticed in previous studies. 4, 22 In a large sample of older non-cardiac surgical patients, Wu et al 29 showed a higher cardiac morbidity rate with a preoperative HTC < 39%. Another study 22 also reported that high-risk patients with a postoperative HTC < 28% more frequently had myocardial ischemia or other morbid cardiac events than those with a higher HTC.
Acute or chronic anaemia requires compensatory responses that place an extra burden on critically ill patients, many of whom have cardiopulmonary diseases. The main theory linking SICU anaemia and postoperative cardiac events is that the stress of surgery combined with increased metabolic demands may lead to cardiac ischemia and death. 31 The impact of anaemia may be physiologically modulated by increased cardiac output, decreased peripheral vascular resistance, and decreased whole blood viscosity (to increase tissue perfusion), but it could be proarrhythmogenic or lead to a cardiac metabolic imbalance. 32 As observed in our results, there was a parallel correlation between increasing HTC levels and decreasing both mortality and MCE rates. Wu and colleagues 29 had also reported that the cardiac event rate increased monotonically for patients with progressively decreased HTC levels. On the other hand, the decreased blood viscosity could explain why patients with a higher HTC more often had a history of cerebrovascular disease. In fact, it was recently reported that an increase in HTC level is related to a decline in parenchymal cerebral blood flow. 33 The limitations of this study are those intrinsic to retrospective cohort studies. Also, the preoperative risk assessment did not consider the evaluation of the patient's functional status, which remains noteworthy in the 2014 cardiovascular assessment European guidelines. 34 However, some studies have reported no substantial association between functional status and MCE or death in the postoperative period. 35 Patients' past medical histories were based on the RCRI, so important comorbidities that influence outcome could be missed. Nevertheless, RCRI remains a reliable cardiac risk index for non-cardiac surgery. In addition, some of the patients included in this study received transfusions, which may have influenced their outcomes.
CONCLUSION
In conclusion, an HTC level < 30% at SICU admission was frequent and appears to be a predictor for poorer outcome in critical surgical patients. We found that a lower HTC was correlated with a higher risk of ARF, MCE, or death during the SICU and hospital stay. HTC was strongly correlated with higher APACHE II and SAPS II scores.
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